Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl Capsules 1 gram
- Published
- 18 Jun 2025
- Units affected
- 11,616 bottles
- Agency
- FDA
- Country
- United States
The hazard
Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Icosapent Ethyl Capsules 1 gram, 120 Capsules per Bottle, Rx Only, Manufactured by Doppel Farmaceutici s.r.l., Piacenza, Italy, Distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-7.
- Brand / company
- Zydus Pharmaceuticals (USA) Inc
- Codes / lots
- Lot #s: B237040, B237041, Exp 10/31/2025
- Distribution
- IL, PA, & MS
- Recall status
- Completed
Source: U.S. Food and Drug Administration, published 18 Jun 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.